<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05049655</url>
  </required_header>
  <id_info>
    <org_study_id>BH-10118-02</org_study_id>
    <nct_id>NCT05049655</nct_id>
  </id_info>
  <brief_title>Medical Data Collection in Subjects Previously Enrolled in ByHeart Protocol SS-101-18</brief_title>
  <official_title>Multi-Center Medical Data Collection in Subjects Previously Enrolled in ByHeart Protocol SS-101-18</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ByHeart</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ByHeart</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational study to generate a long-term outcome database from medical records for&#xD;
      infants who completed protocol SS-101-18.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goals of the registry include: to compile a clinical database of children who were fed in&#xD;
      SS-101-18 by breastfeeding, commercial formula, or ByHeart formula; to investigate any&#xD;
      difference in demographics, growth, development, medical diagnoses, and outcomes between the&#xD;
      feeding groups, and in particular to compare ByHeart formula-fed infants against commercial&#xD;
      formula-fed infants, and referenced against breastfed infants.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">October 2026</completion_date>
  <primary_completion_date type="Anticipated">October 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Growth, Development, Diagnoses, and Long-term Outcomes</measure>
    <time_frame>5 years</time_frame>
    <description>The registry will be utilized to investigate growth, development, diagnoses, and long-term outcomes of infants who received ByHeart study formula, commercially available formula, or breastmilk in the SS-101-18 protocol.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Infant Development</condition>
  <arm_group>
    <arm_group_label>Study Formula</arm_group_label>
    <description>New infant formula fed ad lib</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator Formula</arm_group_label>
    <description>Commercially available infant formula fed ad lib</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Human Milk Reference Group</arm_group_label>
    <description>Human milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Study Formula</intervention_name>
    <description>Babies who were fed study formula during the SS-101-18 study</description>
    <arm_group_label>Study Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Comparator Formula</intervention_name>
    <description>Babies who were fed commercial formula during the SS-101-18 study</description>
    <arm_group_label>Comparator Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Human Milk</intervention_name>
    <description>Babies who were breastfed during the SS-101-18 study</description>
    <arm_group_label>Human Milk Reference Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Approximately 200 infants will be enrolled in this study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Active participation in SS-101-18 through Visit 9&#xD;
&#xD;
          -  Provision of signed and dated informed consent form (ICF) by parent or legally&#xD;
             authorized representative (LAR)&#xD;
&#xD;
          -  Stated willingness to comply with all study procedures by parent or LAR.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Did not participate in SS-101-18&#xD;
&#xD;
          -  Participated in SS-101-18 that withdrew from the study for any reason prior to Visit 9&#xD;
&#xD;
          -  Anything that in the opinion of the Investigator is likely to interfere with&#xD;
             participation in the registry.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Devon Kuehn, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>ByHeart</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alabama Clinical Therapeutics, LLC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Watching Over Mothers &amp; Babies</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>87512</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Children's Clinic of Jonesboro</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PAS Research</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pediatric Associates Mt. Carmel</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45245</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Pediatric Research</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Pediatric Research</name>
      <address>
        <city>Summerville</city>
        <state>South Carolina</state>
        <zip>29486</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holston Medical Group</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

